NEW
Font size
WorksheetsNovomix Q Bank
Total questions: 22
Worksheet time: 16mins
Bebaker et al was published in?
2009
2007
2010
2012
What is the study design of the BeBaker et al?
26 week, open labelled, multicenter, randomized (2:1)
24-week, open labelled, multi-centre, randomized (1:1)
26-week, double blind, multicenter, randomized (2:1)
24 week, double blind, multicenter, randomized (2:1)
In Bebaker et al. after week 14 subjects with what HbA1C were intensified to twice daily NovoMix regimen?
>8.5%
>8.0%
>7.0%
>9.0%
In Bebaker et al. mean reduction with Novomix (OD) in comparison to OADs was
1.34% vs 0.67%
1.24% vs 0.67%
1.7% vs 0.8%
1.5% vs 0.9%
In Bebaker et al. aim is to evaluate the efficacy and safety of adding biphasic insulin aspart 30 (BIAsp30; NovoMix 30) to existing oral antidiabetic agents (OADs) vs. optimizing OADs in a subgroup of Western Pacific patients with type 2 diabetes inadequately controlled on oral monotherapy or oral combination therapy.
True
False
Bebakar et al is a 24-week, multi-centre, open-labelled, randomized, two-arm parallel trial consisted of a 2-week screening period, followed by 24 weeks of treatment.
True
False
In Bebaker et al. Hypoglycaemic episodes were reported in 53% of the patients in BIAsp30 (o.d. and b.i.d. pooled) and 30% of the patients in OAD-only group.
True
False
In Bebaker et al. Subjects randomized to the OAD-only arm (n ¼ 63) continued with their previous OAD treatment.
False
True
In Bebaker et al. all episodes were minor or symptomatic, except for one in each treatment group, which was minor.
True
False
In Bebaker et al. an attempt to reach treatment goals, the dose was optimized (but OAD changed) in accordance to local treatment practice and labelling.
True
False
Sit2Mix was published in which Journal
Diabetes and Obesity
Primary Care Diabetes
Diabetes and Clinical Practice
Diabetes and Metabolism
In Linjawi et al. BIAsp30 added with Sitagliptin + Metformin once or twice daily in T2D patients.
True
False
In Linjawi et al. BIAsp30 was given twice daily without Sitagliptin + metformin
True
False
LINJAWI was a randomized, open Label, three arm parallel group local trial
True
False
Linjawi was published in 2015
False
True
Sit2Mix Aim is to investigate efficacy and tolerability of intensifying diabetes treatment
True
False
linjawi Trial is in insulin naïve patients with duration of
24 week
26 week
12 week
28 week
What was the baseline HBA1c (%) in Sit2Mix.
9.1%
8.4%
7.5%
10%
In Linjawi et al. Observed final HBA1c values are with (BIAsp30 BID + Sit), (BIAsp30 QD + Sit), (BIAsp30 BID – Sit)
6.9%, 7.2%, 7.0%
6.9%, 7.2%, 7.1%
7.1%, 7.2%, 6.9%
In Linjawi et al. Confirmed Hypoglycaemia was lower with BIAsp30 QD + Sit vs BIAsp30 BID + Sit vs BIAsp30 BID.
True
False
In which year Strojek et. All study has been published.
a
2006
2009
2012
2015
In how many weeks Strojek et. All study was conducted.
10 weeks
30 weeks
26 weeks
28 weeks
